We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-12.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.1B
AUM Growth
-$2.55B
(-17%)
Cap. Flow
-$469M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
858
New
52
Increased
315
Reduced
272
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$38.7M |
| 2 |
Apple
AAPL
|
+$27.7M |
| 3 |
Salesforce
CRM
|
+$26.1M |
| 4 |
Verizon
VZ
|
+$25.9M |
| 5 |
PepsiCo
PEP
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.7M |
| 2 |
Waste Management
WM
|
+$64.8M |
| 3 |
Sociedad Química y Minera de Chile
SQM
|
+$58.6M |
| 4 |
Citigroup
C
|
+$56.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.24% |
| 2 | Technology | 24.24% |
| 3 | Financials | 8.36% |
| 4 | Communication Services | 6.82% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Iovance Biotherapeutics
IOVA
$2.23B
| $18M | 0.15% |
1,628,920
+476,335
| +41% | +$6.24M |
|
|
XIFR
152
XPLR Infrastructure LP
XIFR
$1.18B
| $17.6M | 0.15% |
237,997
+21,265
| +10% | +$1.53M |
|
153
Synchrony
SYF
$23.7B
| $17.6M | 0.15% |
637,874
-71,031
| -10% | -$2.47M |
|
154
Hilton Worldwide
HLT
$74B
| $17.6M | 0.14% |
157,745
+75,363
| +91% | +$10.4M |
|
155
Public Storage
PSA
$60.2B
| $17.6M | 0.14% |
56,143
+42,637
| +316% | +$14.8M |
|
156
West Pharmaceutical
WST
$23.1B
| $17.3M | 0.14% |
57,303
-303
| -0.5% | -$98.6K |
|
157
lululemon athletica
LULU
$13B
| $17.3M | 0.14% |
63,505
+7,367
| +13% | +$2.36M |
|
|
HES
158
DELISTED
Hess
HES
| $17.3M | 0.14% |
163,211
-45,293
| -22% | -$5.12M |
|
159
Dollar Tree
DLTR
$23.1B
| $16.8M | 0.14% |
107,520
+95,103
| +766% | +$15.1M |
|
160
Costco
COST
$415B
| $16.7M | 0.14% |
34,764
-33,391
| -49% | -$16.9M |
|
161
Welltower
WELL
$178B
| $16.6M | 0.14% |
201,588
-119,425
| -37% | -$10.6M |
|
162
Humana
HUM
$46.7B
| $16.5M | 0.14% |
35,249
+5,440
| +18% | +$2.42M |
|
|
MRSH
163
Marsh
MRSH
$86.3B
| $16.4M | 0.14% |
105,778
+1,376
| +1% | +$221K |
|
164
Tenable Holdings
TENB
$3.56B
| $16.3M | 0.13% |
+359,981
| New | +$18.5M |
|
165
Ford
F
$57.3B
| $16.3M | 0.13% |
1,463,133
+1,136,873
| +348% | +$15.6M |
|
|
ITOS
166
DELISTED
iTeos Therapeutics
ITOS
| $16.2M | 0.13% |
787,651
+103,839
| +15% | +$2.46M |
|
167
Ally Financial
ALLY
$13.1B
| $16M | 0.13% |
477,337
+46,034
| +11% | +$1.84M |
|
168
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
| $15.9M | 0.13% |
421,137
+80,956
| +24% | +$3.22M |
|
169
Colgate-Palmolive
CL
$72.6B
| $15.9M | 0.13% |
198,307
-110,221
| -36% | -$8.62M |
|
170
Cerence
CRNC
$382M
| $15.7M | 0.13% |
623,273
+210,155
| +51% | +$6.29M |
|
171
Ambarella
AMBA
$2.99B
| $15.5M | 0.13% |
236,605
+5,253
| +2% | +$423K |
|
172
Intel
INTC
$466B
| $15.5M | 0.13% |
413,263
+16,673
| +4% | +$721K |
|
|
KDNY
173
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $15.2M | 0.13% |
871,155
-314,159
| -27% | -$4.93M |
|
|
UMPQ
174
DELISTED
Umpqua Holdings Corp
UMPQ
| $15M | 0.12% |
894,913
+279,110
| +45% | +$4.84M |
|
175
Mondelez International
MDLZ
$77.7B
| $14.7M | 0.12% |
237,343
-7,441
| -3% | -$470K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2022 Portfolio in Review
As of Q2 2022, Candriam SCA held 858 positions worth $12.1B, down 17% from $14.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $469M in Q2 2022, closing 83 positions and reducing 272 holdings. Its most notable exit was TriState Capital Holdings, Inc., an estimated $20.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Tenable Holdings worth $16.3M.
- Candriam SCA's largest Q2 2022 buy was Tenable Holdings: 359,981 shares worth $16.3M.
- Candriam SCA added most to Procter & Gamble in Q2 2022, an estimated $38.7M increase.
- Candriam SCA's biggest Q2 2022 reduction was Microsoft, cutting an estimated $65.7M.
- Candriam SCA fully exited TriState Capital Holdings, Inc. in Q2 2022, selling an estimated $20.9M.
- Candriam SCA's ten largest holdings make up 25% of its $12.1B portfolio in Q2 2022.
- Candriam SCA opened 52 new positions and closed 83 in Q2 2022.
- Candriam SCA's portfolio value fell 17% quarter-over-quarter to $12.1B.
Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.